TW202246494A - 基因改造肝細胞群 - Google Patents

基因改造肝細胞群 Download PDF

Info

Publication number
TW202246494A
TW202246494A TW111102865A TW111102865A TW202246494A TW 202246494 A TW202246494 A TW 202246494A TW 111102865 A TW111102865 A TW 111102865A TW 111102865 A TW111102865 A TW 111102865A TW 202246494 A TW202246494 A TW 202246494A
Authority
TW
Taiwan
Prior art keywords
hepatocytes
cells
human
cell
liver
Prior art date
Application number
TW111102865A
Other languages
English (en)
Chinese (zh)
Inventor
加勒特 海夫納
雷蒙德 希基
邁克爾 福爾摩斯
茗琇 莊
惠特尼 克雷
格倫 邁克希爾
凱倫 佛
斐 易
Original Assignee
美商艾姆比斯藥品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商艾姆比斯藥品公司 filed Critical 美商艾姆比斯藥品公司
Publication of TW202246494A publication Critical patent/TW202246494A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
TW111102865A 2021-01-26 2022-01-24 基因改造肝細胞群 TW202246494A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163141769P 2021-01-26 2021-01-26
US63/141,769 2021-01-26

Publications (1)

Publication Number Publication Date
TW202246494A true TW202246494A (zh) 2022-12-01

Family

ID=82654886

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111102865A TW202246494A (zh) 2021-01-26 2022-01-24 基因改造肝細胞群

Country Status (6)

Country Link
EP (1) EP4284928A2 (fr)
JP (1) JP2024505188A (fr)
KR (1) KR20230136188A (fr)
CA (1) CA3205378A1 (fr)
TW (1) TW202246494A (fr)
WO (1) WO2022164807A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023158836A1 (fr) 2022-02-17 2023-08-24 Sana Biotechnology, Inc. Protéines cd47 modifiées et leurs utilisations

Also Published As

Publication number Publication date
JP2024505188A (ja) 2024-02-05
CA3205378A1 (fr) 2022-08-04
WO2022164807A3 (fr) 2022-08-25
KR20230136188A (ko) 2023-09-26
WO2022164807A2 (fr) 2022-08-04
EP4284928A2 (fr) 2023-12-06

Similar Documents

Publication Publication Date Title
CA3036926A1 (fr) Cellules t de memoire de cellules souches modifiees, procedes de fabrication et procedes d'utilisation correspondants
KR20230074515A (ko) 개선된 기능성 및 지속성을 갖는 붕괴된 레그나제-1 및/또는 tgfbrii를 지니는 유전자 조작된 t 세포
US11591381B2 (en) Gene-edited natural killer cells
US20230272429A1 (en) Modification of blood type antigens
US20210213062A1 (en) Drug-Resistant Immune Cells and Methods of Use Thereof
US20230346836A1 (en) Genetically engineered t cells with disrupted casitas b-lineage lymphoma proto-oncogene-b (cblb) and uses thereof
WO2020228039A1 (fr) Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une meilleure survie et/ou tolérance aux xénogreffes
CN114502181A (zh) 人工抗原特异性免疫调控性t(airt)细胞
TW202246494A (zh) 基因改造肝細胞群
US20220267805A1 (en) Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
US20230381225A1 (en) Methods for the treatment of beta-thalassemia
WO2021072777A1 (fr) Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une survie et/ou une tolérance à une xénogreffe améliorée
US20220228142A1 (en) Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
EP3237644A1 (fr) Méthode d'identification de cellules.
US20230180725A1 (en) Production of Human Cells, Tissues, and Organs in a Growth Factor Receptor-Deficient Animal Host
WO2021072778A1 (fr) Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une survie et/ou une tolérance à une xénogreffe améliorée
Hong et al. Generation of hematopoietic lineage cell-specific chimeric mice using retrovirus-transduced fetal liver cells
CN117580942A (zh) 肝细胞的基因修饰
KR20240011184A (ko) Ciita 표적화 아연 핑거 뉴클레아제
WO2020228043A1 (fr) Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une meilleure survie et/ou tolérance aux xénogreffes
TW202128989A (zh) 具有一個或多個用於增強異種移植物存活和／或耐受性的經修飾基因的細胞、組織、器官和／或動物
CN117916373A (zh) 用于crispr/cas编辑系统的引导rna
WO2024151541A1 (fr) Souris auto-immune présentant un diabète de type 1
WO2023205724A2 (fr) Cellules comprenant un suppresseur d'expression génique et/ou un activateur de voie de synthèse et/ou une charge utile inductible
Pichard et al. Mixed hematopoietic molecular chimerism results in permanent transgene expression from retrovirally transduced hepatocytes in mice